Delisting riskPopularity #4,473
XBIO · NASDAQ · Biotechnology

Xenetic Biosciences (XBIO)

Develops DNase-based adjuncts for cancer therapy and armored CAR-T treatment.

$2.64
After hours+0.07 (+2.72%)
At close$2.57(−14.05%)